The Center for Cancer Computational Biology (CCCB) at the Dana-Farber Cancer Institute has selected CLC bio's enterprise platform for next-generation sequence analysis.
The CCCB provides analytical support services for labs and researchers at the Dana-Farber Cancer Institute.
Over the past two years the CCCB has experienced an increase in the number of researchers who are getting into high-throughput sequencing.
To support this increasing number of molecular biologists and clinicians who didn't have their own bioinformatics resources, CCCB selected CLC bio after seeing how easy it was for users to do analyses and view their data through its interface.
CLC bio's platform also provides versatile deployment opportunities.
By giving individual groups access to CCCB's central installation of the CLC Genomics Server, they were enabled to use a powerful enterprise platform while only needing to invest in their own desktop clients.
CLC bio's enterprise platform comprises user-friendly desktop applications, server software for doing the heavy calculations on existing or new powerful central computers, and centralised data sharing and management.
Furthermore, CLC Genomics Server includes an Application Programming Interface (API) for integration and custom plug-in development.
CLC bio's enterprise platform for Next Generation Sequencing data analysis, CLC Genomics Server, has been awarded the 'Best of Show' prize at the Bio-IT World Conference and Expo 2009, an award judged by a team of Bio-IT-World magazine editors and industry experts.
